Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TENELIGLIPTIN Cause Hepatic function abnormal? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic function abnormal have been filed in association with TENELIGLIPTIN. This represents 2.9% of all adverse event reports for TENELIGLIPTIN.

5
Reports of Hepatic function abnormal with TENELIGLIPTIN
2.9%
of all TENELIGLIPTIN reports
1
Deaths
3
Hospitalizations

How Dangerous Is Hepatic function abnormal From TENELIGLIPTIN?

Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TENELIGLIPTIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TENELIGLIPTIN Cause?

Pemphigoid (29) Hypoglycaemia (8) Off label use (8) Renal impairment (8) Altered state of consciousness (7) Diabetes mellitus inadequate control (7) Diabetes mellitus (6) Interstitial lung disease (6) Cerebral infarction (5) Drug eruption (5)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which TENELIGLIPTIN Alternatives Have Lower Hepatic function abnormal Risk?

TENELIGLIPTIN vs TENIPOSIDE TENELIGLIPTIN vs TENOFOVIR TENELIGLIPTIN vs TENOFOVIR ALAFENAMIDE TENELIGLIPTIN vs TENOFOVIR DISOPROXIL TENELIGLIPTIN vs TEPLIZUMAB-MZWV

Related Pages

TENELIGLIPTIN Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal TENELIGLIPTIN Demographics